Fangzhou Inc. Partners with Tencent Health and Tencent Cloud to Accelerate Development of AI-Enabled Healthcare Services

SHANGHAI, March 26, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced a strategic collaboration with Tencent Health and Tencent Cloud to accelerate AI-driven healthcare solutions by integrating the DeepSeek open-source AI Model on its platform. Following on the Company's local deployment of DeepSeek's open-source large language model in February, the partnership leverages Tencent Cloud's infrastructure to help power Fangzhou's upgraded "AI Agent 2.0" platform.

The "AI Agent 2.0" leverages DeepSeek's analytical capabilities and Tencent's Hunyuan model to enhance the efficiency of pharmaceutical logistics and online healthcare services. Dr. Xie Fangmin, CEO of Fangzhou, emphasized the initiative's goal to "deliver smarter, more efficient solutions for millions of users."

DeepSeek's Competitive Edge: Enabling Cost Efficiency and Data Privacy

DeepSeek's rapid adoption stems from its high performance, cost efficiency, and robust security. Its Mixture-of-Experts (MoE) architecture ensures scalable efficiency, while private deployment ensures compliance with data privacy regulations since customer data is not transmitted to third parties.

As a pioneer in Internet healthcare, Fangzhou's proprietary AI platform, designed for rapid local deployment of multiple large language models, quickly integrated DeepSeek's models. Support from Tencent Cloud's infrastructure has also allowed Fangzhou to enhance its platform's capabilities to better serve patients and healthcare providers.

Deepening Collaboration: Fangzhou and Tencent Pioneer AI-Enabled Healthcare

The deployment of "AI Agent 2.0" represents a milestone in Fangzhou's strategic partnership with Tencent Health and Tencent Cloud. The upgraded system focuses on two core scenarios: patient services and physician workflows, and developing novel functionality and data-driven enhancements.

About Fangzhou Inc.

Fangzhou Inc. (06086.HK) is China's leading online chronic disease management platform, serving 49.2 million registered users and 223,000 physicians (as of December 31, 2024). The Company specializes in delivering tailored medical care and precision medicine solutions. For more information, visit https://investors.jianke.com.

About Tencent

Tencent, a global leader in digital technology, is dedicated to enriching the lives of Internet users, and enhancing operational efficiency for its partners across the healthcare, insurance, and pharmaceutical sectors.

About DeepSeek

Hangzhou DeepSeek Artificial Intelligence Basic Technology Research Co., Ltd. ("DeepSeek") is a Chinese AI firm specializing in large language models (LLMs). Founded in July 2023 and backed by hedge fund High-Flyer, DeepSeek launched its flagship DeepSeek-R1 model and chatbot in January 2025.

Media Contact

For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com 

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements